COVID-19 Status Updates

We realize that COVID-19 has created challenges and uncertainty within the healthcare system, especially for those patients trying to determine which treatment options may be available. To help provide some clarity during this time, we’ve contacted centers around the country to confirm how they are handling the pandemic and how it is affecting enrollment for their multiple myeloma clinical trials. The table below outlines the responses we’ve compiled so far. It includes the enrollment status for each center and the date of the last updated received. We will continue to work with centers to update this on an on-going basis. If you have questions or need further help, we're here for you. Please call us for help (888) 828-2206.

The center is enrolling new patients for their multiple myeloma clinical trials.
The center is considering each patient on a case-by-case basis. Considerations could include the type of trial (such as CAR T or "standard of care"), medical need and availability of resources.
On Hold
The center has placed new enrollment on hold for all myeloma clinical trials.
Center Location Last Updated Status
National Institutes of Health (NIH) Bethesda, MD 4 weeks ago Enrolling
John Theurer Cancer Center Hackensack, NJ 30+ days ago Enrolling
Winship Cancer Institute of Emory University Atlanta, GA 30+ days ago Enrolling
Dana-Farber Cancer Institute Boston, MA 30+ days ago Case-By-Case
Wake Forest Baptist Comprehensive Cancer Center Winston-Salem, NC 30+ days ago Case-By-Case
Memorial Sloan Kettering Cancer Center New York, NY 30+ days ago Case-By-Case
Medical College of Wisconsin Milwaukee, WI 30+ days ago Case-By-Case
Moffitt Cancer Center Tampa, FL 30+ days ago Case-By-Case
UCSF Helen Diller Comprehensive Cancer Center San Francisco, CA 30+ days ago Case-By-Case
UNC Lineberger Comprehensive Cancer Center Chapel Hill, NC 30+ days ago Case-By-Case
City of Hope Comprehensive Cancer Center Duarte, CA 30+ days ago Case-By-Case
Sidney Kimmel Comprehensive Cancer Center Baltimore, MD 30+ days ago On Hold
The University of Texas Southwestern Medical Center Dallas, TX 30+ days ago On Hold
COVID-19 Trial
Myeloma Crowd Introduces Largest COVID-19 Multiple Myeloma Patient Study

The Myeloma Crowd is opening the largest COVID-19 multiple myeloma patient study. Myeloma patients can make a valuable contribution to fighting COVID-19 and receive a free antibody test. We can join together to quickly answer critical questions to help us get through the COVID-19 crisis and come out stronger, healthier and more knowledgeable in the process.

Learn More